IP Verse

Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect

PatentPatent Analysis

EP2992891

UCB PHARMA
Application Number
EP15156237A
Filing Date
Jun 15, 2007
Status
Granted And Under Opposition
Jul 3, 2020
Grant Date
Aug 5, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2301961B9
EP3145504B1
EP2869844B2

Biblio Summary

The patent EP2992891B1 was granted to UCB Pharma on Aug 5, 2020 following the initial filing on Jun 15, 2007 under the application number EP15156237A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBMay 3, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents